Belumosudil Mesylate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Belumosudil Mesylate, covering 2026-02-18 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]